Flow cytometry effectively detects CTCs in melanoma patients, offering a rapid, cost-effective alternative to molecular biology. CTCs are present across all melanoma stages, with a significant ...
Use of an advanced form of the commonly used polymerase chain reaction (PCR) method to analyze circulating tumor cells (CTCs) may greatly increase the ability to diagnose early-stage cancer, ...
Circulating tumor DNA and its correlation with survival in hormone receptor positive HER2-negative stages I-III breast cancer: A systematic review. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early detection plays a crucial role in reducing cancer-related morbidity and ...
The early data in this first patient closely mirror the mechanistic preclinical findings published in Molecular Cancer Therapeutics, which highlight that Paxalisib, when combined with immunotherapy, ...
SAN FRANCISCO — A novel assay for detecting circulating tumor cells (CTCs) holds potential as a screening test for colorectal cancer, because it detects the disease at an early stage, and even detects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results